At a glance
- Originator Schering-Plough
- Class Ischaemic heart disorder therapies
- Mechanism of Action Platelet-derived growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial ischaemia
Most Recent Events
- 01 Nov 1994 Preclinical development for Myocardial ischaemia in USA (Unknown route)